OLIPHANT LAURA 4

What Happened Laura Oliphant, a director of Aehr Test Systems (AEHR), reported an open-market sale of 4,665 shares on 2026-04-16. The shares were sold at $85.59 each for a total of approximately $399,268. This transaction is reported as a sale (code S) — sales are often routine dispositions by insiders and do not necessarily signal a change in company outlook.

Key Details

• Transaction date and price: 2026-04-16 — 4,665 shares sold at $85.59 per share.
• Total value: about $399,268.
• Shares owned after transaction: not disclosed in this filing.
• Footnote: F1 notes the amount reported includes shares subject to unvested restricted stock units (RSUs).
• Filing timeliness: The form was filed with the same report date (2026-04-16) as the transaction.

Context This was an outright sale by a board director (not a purchase or option exercise). Sales by directors can be routine (for diversification, liquidity, tax reasons, etc.) and are less directly informative than purchases. The footnote about unvested RSUs relates to how beneficial ownership is reported and does not, by itself, indicate whether unvested shares were sold.